A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Boston Scientific Corp stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 2,366,189 shares of BSX stock, worth $181 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
2,366,189
Previous 4,710,845 49.77%
Holding current value
$181 Million
Previous $272 Million 40.49%
% of portfolio
0.41%
Previous 0.69%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$57.6 - $68.62 $135 Million - $161 Million
-2,344,656 Reduced 49.77%
2,366,189 $162 Million
Q4 2023

Feb 14, 2024

SELL
$48.64 - $57.81 $83.2 Million - $98.9 Million
-1,710,909 Reduced 26.64%
4,710,845 $272 Million
Q3 2023

Nov 14, 2023

BUY
$50.19 - $54.68 $147 Million - $160 Million
2,931,055 Added 83.97%
6,421,754 $339 Million
Q2 2023

Aug 14, 2023

BUY
$49.72 - $54.64 $85 Million - $93.4 Million
1,708,999 Added 95.92%
3,490,699 $189 Million
Q1 2023

May 15, 2023

BUY
$45.09 - $50.03 $71.4 Million - $79.2 Million
1,583,831 Added 800.44%
1,781,700 $89.1 Million
Q4 2022

Feb 14, 2023

SELL
$39.56 - $47.22 $108 Million - $129 Million
-2,727,904 Reduced 93.24%
197,869 $9.16 Million
Q3 2022

Nov 14, 2022

BUY
$36.71 - $109.66 $6.71 Million - $20 Million
182,829 Added 6.67%
2,925,773 $113 Million
Q2 2022

Aug 15, 2022

BUY
$35.24 - $47.1 $780,354 - $1.04 Million
22,144 Added 0.81%
2,742,944 $102 Million
Q1 2022

May 16, 2022

BUY
$40.9 - $45.1 $33.4 Million - $36.9 Million
817,822 Added 42.98%
2,720,800 $121 Million
Q4 2021

Feb 14, 2022

BUY
$38.07 - $44.87 $31.1 Million - $36.7 Million
817,400 Added 75.3%
1,902,978 $80.8 Million
Q3 2021

Nov 15, 2021

BUY
$41.23 - $45.88 $44.8 Million - $49.8 Million
1,085,578 New
1,085,578 $47.1 Million
Q1 2021

May 17, 2021

SELL
$35.27 - $39.67 $3.35 Million - $3.77 Million
-95,000 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$33.15 - $41.97 $1.56 Million - $1.98 Million
47,140 Added 98.5%
95,000 $3.42 Million
Q3 2020

Nov 16, 2020

BUY
$34.44 - $42.23 $1.65 Million - $2.02 Million
47,860 New
47,860 $1.83 Million
Q1 2020

May 15, 2020

SELL
$25.83 - $45.71 $16.4 Million - $29.1 Million
-636,554 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$37.87 - $45.37 $24.1 Million - $28.9 Million
636,554 New
636,554 $28.8 Million
Q3 2019

Nov 15, 2019

SELL
$40.31 - $43.45 $1.97 Million - $2.12 Million
-48,807 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$34.91 - $42.98 $1.33 Million - $1.64 Million
38,135 Added 357.34%
48,807 $2.1 Million
Q1 2019

May 15, 2019

SELL
$32.91 - $40.75 $4.51 Million - $5.58 Million
-137,040 Reduced 92.78%
10,672 $410,000
Q4 2018

Feb 14, 2019

SELL
$31.73 - $39.04 $92.4 Million - $114 Million
-2,912,215 Reduced 95.17%
147,712 $5.22 Million
Q3 2018

Nov 14, 2018

BUY
$32.83 - $38.63 $52.2 Million - $61.4 Million
1,590,627 Added 108.26%
3,059,927 $118 Million
Q2 2018

Aug 14, 2018

BUY
$26.84 - $34.32 $9.95 Million - $12.7 Million
370,800 Added 33.76%
1,469,300 $48 Million
Q1 2018

May 15, 2018

BUY
$25.2 - $28.54 $27.7 Million - $31.4 Million
1,098,500 New
1,098,500 $30 Million
Q4 2017

Feb 14, 2018

SELL
$24.79 - $29.8 $3.11 Million - $3.74 Million
-125,500 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$26.26 - $29.17 $3.3 Million - $3.66 Million
125,500
125,500 $3.66 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $110B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.